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Background: Native bees of the tribe Meliponini produce a distinct kind of propolis called geopropolis. Although
many pharmacological activities of propolis have already been demonstrated, little is known about geopropolis,
particularly regarding its antimicrobial activity against oral pathogens. The present study aimed at investigating the
antimicrobial activity of M. fasciculata geopropolis against oral pathogens, its effects on S. mutans biofilms, and the
chemical contents of the extracts. A gel prepared with a geopropolis extract was also analyzed for its activity on S.
mutans and its immunotoxicological potential.
Methods: Antimicrobial activities of three hydroalcoholic extracts (HAEs) of geopropolis, and hexane and
chloroform fractions of one extract, were evaluated using the agar diffusion method and the broth dilution
technique. Ethanol (70%, v/v) and chlorhexidine (0.12%, w/w) were used as negative and positive controls,
respectively. Total phenol and flavonoid concentrations were assayed by spectrophotometry. Immunotoxicity was
evaluated in mice by topical application in the oral cavity followed by quantification of biochemical and
immunological parameters, and macro-microscopic analysis of animal organs.
Results: Two extracts, HAE-2 and HAE-3, showed inhibition zones ranging from 9 to 13 mm in diameter for S.
mutans and C. albicans, but presented no activity against L. acidophilus. The MBCs for HAE-2 and HAE-3 against S.
mutans were 6.25 mg/mL and 12.5 mg/mL, respectively. HAE-2 was fractionated, and its chloroform fraction had an
MBC of 14.57 mg/mL. HAE-2 also exhibited bactericidal effects on S. mutans biofilms after 3 h of treatment.
Significant differences (p < 0.05) in total phenol and flavonoid concentrations were observed among the samples.
Signs toxic effects were not observed after application of the geopropolis-based gel, but an increase in the
production of IL-4 and IL-10, anti-inflammatory cytokines, was detected.
Conclusions: In summary, geopropolis produced by M. fasciculata can exert antimicrobial action against S. mutans
and C. albicans, with significant inhibitory activity against S. mutans biofilms. The extract with the highest flavonoid
concentration, HAE-2, presented the highest antimicrobial activity. In addition, a geopropolis-based gel is not toxic
in an animal model and displays anti-inflammatory effect.
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Propolis is a generic name used for the product that
results from the addition of the mandibular secretions
of various bee species to resins these insects collect
from the buds, flowers and exudates of different plants
[1]. Distinct pharmacological activities of propolis have
been demonstrated, including antimicrobial, anti-inflam-
m a t o r y ,a n t i t u m o r ,c y t o t o x i c ,h e p a t o p r o t e c t i v ea n d
immunomodulatory properties, among others [2-4]. This
diversity of pharmacological activities is related to quan-
titative and qualitative variations in the composition of
different propolis samples [5,6].
Known pharmacological activities generally refer to
propolis produced by Apis mellifera, the most common
bee species in many countries and the main producer of
honey in those countries [7]. However, some of these
activities have also been observed in propolis produced
by other bee species, including members of the tribe
Meliponini [6,8]. Meliponines are stingless bees native
to tropical and subtropical regions [9]. In the north and
in some states of northeastern Brazil, Melipona compres-
sipes fasciculata is the most important species for honey
bee production and play an important role in flower
pollination [10]. Stingless bees generally mix resinous
material that they collect from plants with wax and soil
and store large deposits of this material, called geopro-
polis, inside their hives. The final product is then used
in a similar manner as propolis produced by A. mellifera
[11].
In some countries, geopropolis has been used empiri-
cally by the population for wound healing, for the treat-
ment of gastritis, and as an antibacterial agent [12].
Studies of ethanolic extracts of geopropolis produced by
M. compressipes and M. quadrifasciata anthidioides
have demonstrated its antimicrobial activity [13].
Although recent studies of M. quadrifasciata geopro-
polis have shown inhibitory activity against Gram-nega-
tive bacteria [14], this activity seems to be more
pronounced against Gram-positive bacteria [6,8]. These
results may be correlated with variations in chemical
content, as has been observed for other types of propolis
[13,15].
Due to its inhibitory effects on cariogenic microorgan-
isms, such as Streptococcus mutans and Lactobacillus
spp., and on bacterial enzymes (glucosyltransferases)
involved in the cariogenic process, A. mellifera propolis
has been proposed as an adjuvant for the control or
prophylaxis of infectious diseases of the oral cavity, par-
ticularly dental caries [16-20].
Besides the pharmacological properties of propolis, its
addition to different commercial products has drawn the
attention of researchers for its possible toxicity, such as
the triggering of hypersensitivity in the user. Most
results show that the use of Apis propolis is relatively
safe, since it presents low toxicity [21-25].
Thus, the objective of the present study was to investi-
gate the antimicrobial activity of M. fasciculata geopro-
polis extracts against oral pathogens, its effects on the
viability of S. mutans biofilms, and the chemical con-
tents of the extracts. A gel prepared with a geopropolis
extract was further analyzed for its antimicrobial activity
on S. mutans and its immunotoxicological potential.
Methods
Preparation and fractionation of geopropolis extracts
Samples of geopropolis produced by M. fasciculata were
collected from bee hives located in the municipalities of
Palmeirândia and São Bento, a microregion of the Wes-
tern Lowland of Maranhão (2°37’30"S 44°52’30"W), the
ecosystems of which include mangrove swamps, flood-
plains, lakes, and babassu palm forests, and in the muni-
cipality of Fernando Falcão, a microregion of Alto
Mearim and Grajaú (6°7’30"S 44°52’30"W), a savannah
area. These municipalities are situated in the northwes-
tern and central region of the State of Maranhão, in
northeastern Brazil.
Individual geopropolis samples were weighed and
mixed with ethanol (70%, v/v) to a final proportion of
geopropolis/ethanol of 30/70 (w/v). Next, the samples
were triturated in a homogenizer and macerated for 48
h. The samples were then filtered through filter paper to
remove the inorganic portion (soil), concentrated in a
rotary evaporator and air-dried at 40°C for 48 h. The
three hydroalcoholic extracts obtained (HAE-1, HAE-2
and HAE-3) were stored in a refrigerator (4-8°C) until
the time of analysis. The crude extract presenting the
highest activity, HAE-2, was fractionated by liquid/liquid
partitioning using solvents of different polarities (hexane
and chloroform) [26]. The fractions obtained, HAE-2-
HF (hexane fraction) and HAE-2-CF (chloroform frac-
tion), were concentrated, dried and stored as described
above.
Preparation of a geopropolis-based gel
A geopropolis-based gel was prepared by mixing HAE-2
with 70% (w/v) Natrosol
® and 30% (v/v) propylenoglicol,
as vehicle, for the formulation of a 5% (w/w) gel. Patent
pending under No. PI0905583-5 INPI-RIMA, Brazil.
Animals
C57Bl/6 mice, weighting 25-35 g, from the Central Ani-
mal Facility of the Federal University of Maranhão were
used in the experiments with the geopropolis gel. The
study was approved by the Ethics Committee for Animal
Studies of the State University of Maranhão (No. 010/
2007). All animals were cared for in accordance with
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In vitro evaluation of antimicrobial activity
Antimicrobial activity was evaluated using the agar dif-
fusion method. For this study, 25 μL of extract was
added to wells (5 mm in diameter) in agar plates as
described previously [27]. The following culture media
were used: brain-heart infusion agar (BHI agar, Difco)
for S. mutans, Rogosa agar (Difco) for Lactobacillus
acidophilus, and Sabouraud dextrose agar (Difco) for
Candida albicans. Twenty-four-hour cultures of S.
mutans (ATCC 25175), L. acidophilus (ATCC 4356)
and C. albicans (ATCC 18804) were used. Cultures
were adjusted with sterile saline to a density equivalent
to the McFarland scale No. 0.5 (10
8 CFU/mL) and
inoculated onto agar plates with a sterile swab. Ethanol
(70%, v/v) and an aqueous solution of chlorhexidine glu-
conate (0.12%, w/w) were used as negative and positive
controls, respectively. Plates of S. mutans and L. acido-
philus were incubated at 37°C for 48 h in 5% CO2. C.
albicans plates were incubated under aerobic conditions
at 37°C for 24 h. After incubation, the diameters of the
zones of inhibition were measured.
The minimum bactericidal concentrations (MBCs)
were determined by the broth dilution technique using
BHI broth (Difco). The final concentrations of tested
hydroalcoholic extracts ranged from 12.5 to 0.19 mg/mL
except the chloroform fraction (HAE-2-CF) for which
concentrations ranged from 20 to 0.9 mg/mL. All assays
were carried out in duplicate in three independent
experiments. Dilutions of hydroalcoholic extracts were
streaked on BHI agar plates and the MBC was deter-
mined. The MBC was defined as the lowest concentra-
tion of the extract that inhibited bacterial growth [28].
The minimum inhibitory concentration (MIC) for the
geopropolis-based gel, against S. mutans (ATCC 25175),
was determined by the broth dilution technique using
BHI broth (Difco). The final concentrations of the pro-
duct varied from 50 to 3.12 mg/mL and the minimum
bactericidal concentration (MBC) was determined as
described above.
Inhibition of biofilm viability
The effect of HAE-2 on the viability of S. mutans
(ATCC 25175) biofilms was evaluated as described pre-
viously [29,30], with some modifications. Briefly, for bio-
film production, 24-well polystyrene cell-culture plates
(TPP, Zellkultur und Labortechnologie, Switzerland)
containing 1 mL tryptone-yeast extract broth supple-
mented with 1% sucrose were inoculated with approxi-
mately 1 × 10
6 CFU/mL of S. mutans. The culture
medium was changed daily. On the fourth day, the cul-
ture supernatant was removed by aspiration, the
bacterial biofilm was treated with HAE-2 diluted in 1%
peptone broth at a concentration corresponding to four
times its MBC (25 mg/mL), and bacterial counts were
evaluated at different intervals. The negative control
well contained only 1% peptone broth and chlorhexidine
(0.12%) was used as the positive control [31]. The treat-
ment solution was removed by aspiration at 1-h inter-
vals for 4 h, and the biofilm was gently washed three
times with phosphate-buffered saline (PBS), pH 7.2,
scraped off, and suspended in 1 mL 1% peptone broth.
The suspension was sonicated twice in a Model T7 soni-
cating water bath (Thornton, Brazil) at 50 W with three
pulses of 10 s each at intervals of 5 s [30]. After homo-
genization, the suspension was diluted from 10
-1 to 10
-4
in PBS. Aliquots (100 μL of each dilution) were spread
onto blood agar plates (blood agar base containing 5%
sheep blood) and incubated in a 5% CO2 atmosphere at
37°C for 48 h. After incubation, CFU/mL were deter-
mined. These data were log10 transformed for analysis.
All assays were carried out in quadruplicate.
A bactericidal effect was attributed to geopropolis
e x t r a c tw h e ni tr e s u l t e di nar e d u c t i o no f≥ 3l o g 10
CFU/mL above baseline [30].
Chemical characterization
Phenolic compounds, triterpenes and alkaloids were
assayed in all extracts as described previously [32-34].
Total phenol concentration was assayed by spectropho-
tometry with the Folin-Ciocalteau reagent (Merck, Bra-
sil) and 20% sodium carbonate solution for 2 h at
room temperature in the dark. Known concentrations
of gallic acid were used as standards. Measurements
were made in a spectrophotometer (Cary 50 UV-VIS,
Agilent, USA) at 760 nm and the results were
expressed as a percentage of gallic acid [33]. The cali-
bration equation for gallic acid (Sigma) was y =
0.06352x - 0.06132 (R
2 =0 . 9 9 )w h e r ey is absorbance
and x is mg/mL of gallic acid.
The concentration of total flavonoids was determined
by spectrophotometry in 2% aluminum chloride for 30
min at room temperature in the dark. Known concen-
trations of quercetin were used as standards and mea-
surements were made at 425 nm. The results were
expressed as a percentage of quercetin [33]. The calibra-
tion equation for quercetin (Merck) was y = 0.07347x -
0.00868 (R
2 = 0.99) where y is absorbance and x is mg/
mL of quercetin. After linear regression analysis (CI
95%), both gallic acid and quercetin showed linear
responses with different concentrations in the residue
analysis. The relative standard deviations of the slopes
were ≤ 5% for both standards (gallic acid, n = 9; querce-
tin, n = 6).
According to the Brazilian legislation, total phenols
and flavonoids contents should be included in the
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polis extracts [35].
The detection of triterpenes was performed by the
Lieberman-Buchard reaction.B r i e f l y ,2m Lo fe x t r a c t
were mixed with 2 mL of chloroform. The mixture was
filtered in the presence of Na2SO4 and 1 mL of acetic
anhydride was added. After the addition of 3 drops of
concentrated H2SO4, a change in color to brownish/red
indicated the presence of triterpenes [32].
Total alkaloid content of extracts was determined
using the Dragendorff’s, Hager’s, and Mayer’sr e a g e n t s
[34]. Three aliquots of dried geopropolis extracts (10
mg) were dissolved in 1 mL of distilled water that had
been acidified to pH 2.0-2.5 with 0.01 N HCl. Alkaloids
were then investigated with 5 drops of each reagent
separately in each tube.
Animal experimental procedures
The animals were divided in three groups of 6 animals
each, as follows: saline (S) - received a topical application
of a sterile 0.85% NaCl (w/v) solution; GS - received a
topical application of the pure gel base; and GP - received
the gel base with HAE-2. The gel was applied topically to
the oral cavity of the mice (25 μL/application), for a per-
iod of 1 minute, on four consecutive days.
Assessment of biochemical parameters and cytokine
production
For the biochemical and immunological analysis, blood
samples were collected from the retro-orbital plexus on
the seventh day after treatment. The samples were
transferred to conical plastic tubes, with or without
EDTA, and centrifuged at 1500 rpm for 10 minutes.
Biochemical assessment consisted of a micro-assay to
determine the serum concentrations of calcium, urea,
cholesterol, triglycerides, albumin and glucose. The ana-
lysis were performed by means of automated procedures
on an Architect - C8000 apparatus (Abbott
®), using
reagents from Labtest (Brazil). The concentrations of
IFN-g,I L - 4 ,T N F - a and IL-10 were determined by
immunoenzymatic assay (enzyme-linked immunosorbent
assay; ELISA), according to the manufacturer’si n s t r u c -
tions (eBiosciences). Recombinant cytokines were used
to generate a standard curve. The limit for detection in
the assay was 2 pg/mL for IFN-g,T N F - a,a n dI L - 4 ,a n d
4 pg/mL for IL-10. The concentrations of cytokines
were established using the coefficient of linear regres-
sion from values obtained on the standard curve.
Macro- and microscopic assessment of the organs
The macroscopic analysis of the tongue, spleen, liver, sto-
mach, and kidney considered the following parameters:
size, weight, integrity and presence or not of changes
visually detectable. Only the tongue was not weighed. For
the histopathological analysis, all organs were fixed in
10% formol and embedded in paraffin. Next, 5 μmt h i c k
sections were cut on a microtome and stained with
hematoxylin and eosin. The slides were examined in a
light microscope with 20, 40 and 100× objectives. The
following parameters were analyzed: the presence of vas-
cular congestion, edema, inflammatory infiltrate, and
hemorrhage. Tissue changes were scored as: 0 for absent,
1 for scarce, 2 for moderate and 3 for intense.
Statistical analysis
The results were analyzed using SPSS for Windows 16.0
software (2007). Inhibition zones were compared using
the Mann-Whitney test. Total phenol and flavonoid
concentrations in the extracts as well as bactericidal
effects of geopropolis on S. mutans biofilm viability
were evaluated by analysis of variance (ANOVA) in con-
junction with the Tukey multiple comparisons test. Data
obtained with animals were expressed as mean ± stan-
dard deviation (X ± SD) for the immunological and bio-
chemical results, and as mean ± standard error for the
histopathological data. Statistical analysis consisted of
analysis of variance (ANOVA), followed by Newman-
Keuls test. Organ weights were subjected to Tukey’s test
and the histopathological data were analyzed by
unpaired and single-tailed Student’s t-tests. For all tests,
effects were considered significant when p < 0.05.
Results
Agar diffusion tests showed the antimicrobial action of
geopropolis extracts (HAE-2 and HAE-3), with inhibi-
tion zones ranging from 10 to 13 mm for S. mutans and
f r o m9t o1 3m mf o rC. albicans. No activity against L.
acidophilus was detected (Table 1). HAE-2 and HAE-3
Table 1 In vitro activity of geopropolis extracts against
Streptococcus mutans, Lactobacilus acidophilus and
Candida albicans
Extracts
a Inhibition zone in mm (X ± SD)
b





HAE-2 13 ± 1
cd 13 ± 3
b 0
d












Chlorhexidine (0.12%) 23 ± 1 15 ± 2 20 ± 3
Ethanol (70%) 00 0
a Extracts of geopropolis from different municipalities, as shown in Table 1.
b Average of agar diffusion tests performed in duplicate in three independent
experiments.
c Significantly different from negative control (70% ethanol).
d Significantly different from positive control (0.12% chlorhexidine) (p < 0.05;
Mann-Whitney test).
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mutans and C. albicans when compared to the negative
c o n t r o l( p<0 . 0 5 ) .H A E - 1s h o w e dn oa n t i m i c r o b i a l
activity against the microorganisms tested.
Evaluation of the antimicrobial activity of HAE-2 frac-
tions revealed that only the chloroform fraction showed
an inhibition zone when tested against S. mutans (13
mm). No antimicrobial activity of the hexane or chloro-
form fractions was observed against C. albicans.T h e
MBC against S. mutans was 6.25 mg/mL for HAE-2,
12.5 mg/mL for HAE-3, and 14.5 mg/mL for the chloro-
form fraction HAE-2-CF. The MBC of geopropolis-
based gel (prepared with HAE-2) against S. mutans was
confirmed in 12.5 mg/mL.
Since HAE-2 presented a lower MBC than the other
extracts and since the pathogenesis of the cariogenic
process is related to the formation of a dental biofilm,
we investigated whether this extract was able to inhibit
the viability of S. mutans biofilms. A significant reduc-
tion in CFU/mL was observed after 2 h exposure of a
biofilm to geopropolis extract HAE-2 or chlorhexidine
(Figure 1). However, bactericidal effects were observed
after 3 h treatment with geopropolis extract (reductions
higher than 3log10 were obtained). Chlorhexidine treat-
ment resulted in total elimination of S. mutans after 3 h
exposure to the biofilm.
Chemical characterization of the geopropolis extracts
indicated the presence of phenolic compounds in all
samples. There were significant differences (p < 0.05) in
total phenol and flavonoid concentrations among the
samples analyzed (Table 2). Phenol content differed
among the three extracts studied, with the lowest con-
centration being observed in HAE-2. In contrast, this
extract contained the highest concentration of flavonoids.
Triterpenes were detected in HAE-1 and HAE-2, but not
HAE-3; alkaloids were not detected in any sample.
The experimental procedures with animals did not
lead to any alteration in the serum concentration of cal-
cium, albumin, and glucose in the GP group. On the
other hand, animals in this group presented an
increased concentration of urea and reduced concentra-
tions of cholesterol, and triglycerides (Figure 2).
A significant increase in the production of IL-4 and
IL-10 was observed in the GP group, while the produc-
tion of IFN-g and TNF-a was kept unaltered when com-
pared to the S and the GS groups (Figure 3).
No significant changes were observed in the body
weight of the animals and also in relation to the organs
weight, with the exception of the stomach in the GS
group (Table 3). Besides, no macro- or microscopic
alteration was detected in the liver, kidney, or stomach.
However, histopathological alterations, such as: vascular
congestion, presence of edema, inflammatory infiltrate,
and hemorrhage in the animal tongues, were signifi-
cantly greater in the GS and S groups than in the GP
group (Table 4).
Discussion
In this study we observed that geopropolis can display
inhibitory effects on some oral pathogens, without
detectable toxicity in mice. Furthermore, an immuno-
modulatory activity, due to an increased anti-inflamma-
tory cytokines, was also detected.
The inhibitory activity displayed by geopropolis
against S. mutans and C. albicans was previously
observed in extracts and fractions obtained from Apis
propolis [15-17,19,20,36,37]. However, none of the three
geopropolis extracts tested in this study were seen to
have antimicrobial activity against L. acidophilus, unlike
propolis extracts [38].
The inhibitory activity of geopropolis against S.
mutans and C. albicans,b u tn o ta g a i n s tL. acidophilus,
corresponds with the clinical significance of these
microorganisms in oral cavity diseases. Both S. mutans
and L. acidophilus ferment carbohydrates, forming
organic acids that promote decalcification of dental
enamel and dentine. Thus, the presence of these micro-
organisms is frequently associated with dental caries
[39,40]. S. mutans is responsible for the initial deminera-
lization of dental enamel, whereas bacteria of the genus
Lactobacillus are related to lesion progression, i.e., after
the initiation of the caries process [41]. Therefore, we
speculate that a product containing M. fasciculata geo-
propolis, which mainly acts on S. mutans,m a yh a v e
important implications for caries-prevention strategies
because S. mutans growth and biofilm formation are
required for the onset of dental caries.
Figure 1 Bactericidal effects of HAE-2 on the viability of S.
mutans biofilms. (a) p < 0.05 Effects in relation to time 0; (b) p <
0.05 Comparison of geopropolis activity on the biofilm viability in
relation to the control (1% peptone broth) and (c) p < 0.05
Comparison of geopropolis activity on the biofilm viability relative
to chlorhexidine. Comparisons were analyzed using the Tukey test.
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activities of geopropolis produced by native bees such as
M. fasciculata, especially regarding its activities against
oral microorganisms. A recent in vivo study showed that
geopropolis produced by M. fasciculata promoted a
reduction in salivary S. mutans counts [42]. However,
the authors did not investigate the effects of geopropolis
on other microorganisms, and no in vitro tests were
performed. We found no other studies in the literature
investigating the antimicrobial activity of geopropolis
produced by M. fasciculata against S. mutans. Thus, the
present findings are especially relevant since they under-
score the potential for finding new active compounds
that work against this microorganism in M. fasciculata
geopropolis extracts.
The bactericidal activity of geopropolis extracts we
observed against S. mutans biofilms is relevant not only
because it confirms our in vitro results but also because
it more closely reproduces the real conditions of the
cariogenic process. Biofilm models are more relevant
than studies which use planktonic cells because of the
different growth of biofilm cells, their altered
Table 2 Phenol and flavonoid concentrations of hydroalcoholic geopropolis extracts
Extract City Total Phenol % (± SD)
a, b Total Flavonoids % (± SD)
a, c
HAE-1 Fernando Falcão 67.4 (2.0)
d 1.07 (0.04)
f
HAE-2 Palmeirândia 14.6 (2.3)
e 2.91 (0.22)
d
HAE-3 São Bento 51.2 (3.9)
f 1.11 (0.01)
f
a Results are expressed as the average of assays carried out in triplicate.
b Expressed as percentage of gallic acid.
c Expressed as percentage of quercetin.
d, e, f Values followed by different superscripts are significantly different from each other (p < 0.05; Tukey test).
Figure 2 Biochemical assessment. Biochemical assessment of C57Bl/6 mice submitted to topical oral treatment with gel containing propolis
(GP), compared to the group treated with the gel base (GS) or with saline (S). The serum concentrations of calcium (A); albumin (B); urea (C);
cholesterol (D); triglycerides (E); and glucose (F) were determined. The results represent mean ± standard deviation of 6 animals/group. (*) p <
0.05 in relation to control and (#) p < 0.05 in relation to the other experimental group.
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their generally higher resistance to antimicrobial agents
[43].
Despite the significant in vitro antimicrobial activity of
chlorhexidine against S. mutans biofilms, its use in den-
tistry is controversial because of local side effects, which
include discoloration of the teeth, tongue, restorations,
and dentures; soreness of the oral mucosa; and irritation
of taste buds [44].
C. albicans is considered a commensal microorganism,
inhabiting the oral mucosa and other anatomic sites.
However, in certain situations, this microorganism can
cause opportunistic local or systemic infections that are
often severe and difficult to control, especially in hosts
with specific predisposing factors [45,46]. Thus, in addi-
tion to being used to control S. mutans growth, pro-
ducts formulated from M. fasciculata geopropolis might
be used as adjuvants for the treatment of oral candidia-
sis and, ultimately, infections of other mucosa.
Chemical characterization of the extracts studied
showed significant differences in the concentration of
phenols and flavonoids among samples. The chemical
composition of geopropolis produced by stingless bees
in Brazil varies according to species. Moreover, available
flora further influence the chemical composition of pro-
polis [47]. According to Velikova et al. [6], members of
the tribe Meliponini fly short distances and therefore
use the first exudate sources that they encounter during
their flights.
Only one of the propolis extracts (HAE-1) analyzed
failed to show inhibitory activity against the microorgan-
isms tested in this study, a finding that would suggest
variations in the chemical composition of this sample.
However, preliminary chemical analysis performed did
Figure 3 Serum concentration of cytokines. Serum concentration of cytokines in C57Bl/6 mice treated with topical oral gel containing
propolis (GP) in comparison with the group treated only with the gel base (GS), or with saline (S). ELISA was used to determine the serum
concentrations of IL-4 (A); IL-10 (B); IFN-g (C) and TNF-a (D). The results represent mean ± standard deviation of 6 animals/group. (*) p < 0.05 in
relation to the control and (#) p < 0.05 in relation to the other experimental group.
Table 3 Effect of topical oral treatment with a gel based on geopropolis (GP) from Melipona fasciculata Smith on
organ weight in mice.
Groups Final Weight (g) Delta Weight Organ weights (g)
Spleen Kidney Stomach Liver
GP 25 ± 4 0.2 0.08 ± 0.01 0.16 ± 0.03 0.42 ± 0.06 1.3 ± 0.2
S 28 ± 2 -0.2 0.10 ± 0.02 0.18 ± 0.02 0.33 ± 0.04 1.6 ± 0.2
GS 27 ± 2 -0.2 0.09 ± 0.01 0.17 ± 0.01 0.55 ± 0.08* 1.5 ± 0.2
* p < 0.05 (ANOVA, followed by Tukey’s test.)
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ences in its chemical content may have been influenced
by its ecosystem because it originated in a savannah
area, whereas HAE-2 and HAE-3 were prepared with
geopropolis from an ecosystem whose vegetation com-
prised mangrove swamps, floodplains, lakes, and babassu
palm forests.
Qualitative and quantitative differences in the compo-
sition of propolis have an important influence on its
biological activity [48]. Among biologically active sub-
stances present, flavonoids are the main group contri-
buting to the antimicrobial effects observed [21,49]. In
this study, HAE-2 displayed the highest antimicrobial
activity and had the greatest flavonoid concentration.
Although the antimicrobial action of flavonoids is still
controversial and conflicting results have been reported
because of inter- and intra-assay variations in suscept-
ibility tests, a link between flavonoids and inhibitory
activity on microorganisms has been consistently
demonstrated [50]. The antimicrobial activities observed
here may be a product of high flavonoid concentration
or, as reported for propolis produced by other bee spe-
cies, a result of a synergistic action between flavonoids
and other compounds present in these extracts [6,13].
Although some studies have reported cases of hyper-
sensitivity reactions to Apis propolis [51,52], it is widely
accepted that propolis does not present toxic effects
[53,54], which confirms the results obtained with geo-
propolis in our study, since no macro and microscopic
changes were detected in organs, which could indicate
toxicity of the geopropolis-based gel on the mice.
Moreover, among the biochemical parameters studied,
only an increase in the urea concentration was detected,
but within the normal range for mice (41,97 mg/dl to
60,02 mg/dl), which does not indicate renal toxicity[55].
In fact, compounds like flavonoids, caffeic acid, and
their esters present in propolis appear to prevent against
membrane fragility in organs such liver and kidney,
decreasing the level of urea and the leakage of liver
enzymes into the circulation [54,56,57].
The reduction observed in the levels of cholesterol
and triglycerides can be associated to the presence of
antioxidants and flavonoids. Apparently, these com-
pounds can act as inhibitors of lipid peroxidation (LPO)
by scavenging polyunsaturated fatty acids’ peroxy radi-
cals and interrupt the chain reactions [58].
Despite not having shown signs of toxicity, the
increased production of IL-4 and IL-10, cytokines asso-
ciated with a Th2 response, suggests an anti-inflamma-
tory activity for the product [59]. In fact, the
histopathological assessment of the tongue corroborates
t h e s ed a t a ,s i n c et i s s u ec h a n g e sw e r es i g n i f i c a n t l yl o w e r
in the GP group, possibly because of the anti-inflamma-
tory effects of the geopropolis. Tissue alterations in the
other animal groups were probably resulting from their
manipulation at the time of treatment and/or collection
of the material.
The immunomodulatory effect displayed has been pre-
viously reported in investigations with Apis propolis
[4,60-63]. However, we did not find any reports describ-
ing the effects of geopropolis from native bees on the
production of cytokines, specifically IL-4 and IL-10.
The potential use of propolis (or geopropolis) in den-
tistry is promising not only due to its antimicrobial
activity against oral pathogens, but also due to its other
biological and pharmacological properties, which include
anti-inflammatory, antitumor, antioxidant, hematostimu-
lative, and immunomodulatory properties [2,4,64,65]. In
addition, it is considered relatively non-toxic [21,22].
Conclusions
In conclusion, our data indicate that geopropolis pro-
duced by M. fasciculata can exhibit antimicrobial activ-
ity against S. mutans and C. albicans. The activity
against S. mutans was confirmed by further demonstrat-
ing the antibacterial effect of one extract on biofilm via-
bility. The extract with the highest flavonoid
concentration, HAE-2, displayed the highest antimicro-
bial activity. The gel maintained the antibacterial activity
previously demonstrated in the geopropolis extract
against S. mutans. Furthermore, no toxic effects were
detected in mice treated with GP. On the other hand,
an immunomodulatory action, due to the increase of
anti-inflammatory cytokines, was observed. Our data
demonstrate that geopropolis has the potential to be
used for the control or prevention of diseases of the oral
cavity, especially caries and candidiasis, as well as for
treatment of inflammatory processes.
List of Abbreviations
HAE: Hydroalcoholic extracts of geopropolis; MBC: Minimum bactericidal
concentration; HAE-2-CF: Chloroform fraction of hydroalcoholic extract No. 2
Table 4 Histopathological analysis of the tongue in mice
that received topical oral treatment with a gel based on





Vascular Congestion 0.4 ± 0.1*
# 1.8 ± 0.2
b 1.6 ± 0.1
Edema 0*
# 1.2 ± 0.2 0.4 ± 0.1*
Inflammatory Infiltrate 0.2 ± 0.1* 1.2 ± 0.1 0 *
Hemorrhage 0.4 ± 0.1* 2.2 ± 0.2 0.4 ± 0.1*
(a) Tissue changes were scored as: 0 for absent, 1 for scarce, 2 for moderate
and 3 for intense. Data represent the mean ± SEM of 6 animals per group
(b) GP - gel with geopropolis; GS - gel base and S - Saline
(*) p < 0.05 in relation to GP
(#) p < 0.05 in relation to S
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geopropolis; BHI: Brain-Heart Infusion; ATCC: American Type Culture
Collection; CFU: Colony-forming unit; PBS: Phosphate-buffered saline.
Acknowledgements
The authors wish to thank the Conselho Nacional de Desenvolvimento
Científico e Tecnológico (CNPq) and the Banco do Nordeste for financial
support and the Fundação de Amparo a Pesquisa e ao Desenvolvimento
Científico e Tecnológico do Maranhão (FAPEMA) for the fellowship support.
Author details
1Laboratório de Imunofisiologia, Universidade Federal do Maranhão, Av. dos
Portugueses, SN, CEP: 65.080-040, São Luís, Maranhão, Brazil.
2Departamento
de Odontologia, Universidade Federal do Maranhão, Av. dos Portugueses,
SN, CEP: 65.080-040, São Luís, Maranhão, Brazil.
3Laboratório de
Microbiologia, Universidade Federal do Maranhão, Av. dos Portugueses, SN,
CEP: 65.080-040, São Luís, Maranhão, Brazil.
4Laboratório de Farmacognosia,
Universidade Federal do Maranhão, São Luís, Av. dos Portugueses, SN, CEP:
65.080-040, Maranhão, Brazil.
5Laboratório de Microbiologia, Centro
Universitário do Maranhão, Rua Josué Montello No. 1, CEP: 65.075-120, São
Luís, Maranhão, Brazil.
Authors’ contributions
SAL prepared the extracts, carried out the microbiological evaluation,
organized the data analysis and drafted the manuscript. ALAP assisted with
the data analysis and helped draft the manuscript. RPD carried out the
chemical characterization and partitioned the extracts. ASR collected the
geopropolis samples and helped with preparation of extracts. MJAMA
helped with preparation of geopropolis extracts and animal experimental
procedures. NSM helped with animal experimental procedures. LAS carried
out histopathological analysis. MNSR participated in chemical
characterization and helped draft the manuscript. FRFN helped with data
analysis and manuscript revision. RNMG conceived the study, participated in
its design and coordination, and critically reviewed the manuscript for
important intellectual content. VMN conceived the study, coordinated the
microbiological assays, and was involved in drafting the manuscript and
revising it critically for intellectual content. All authors read and approved
the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 June 2011 Accepted: 4 November 2011
Published: 4 November 2011
References
1. Ghisalberti EL: Propolis: A review. Bee World 1979, 60:59-84.
2. Banskota AH, Tezuka Y, Adnyana IK, Midorikawa K, Matsushige K,
Message D, Huertas AA, Kadota S: Cytotoxic, hepatoprotective and free
radical scavenging effects of propolis from Brazil, Peru, the Netherlands
and China. J Ethnopharmacol 2000, 72(1-2):239-246.
3. Dobrowolski JW, Vohora SB, Sharma K, Shah SA, Naqvi SA, Dandiya PC:
Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic
studies on propolis bee products. J Ethnopharmacol 1991, 35(1):77-82.
4. Sforcin JM: Propolis and the immune system: a review. J Ethnopharmacol
2007, 113(1):1-14.
5. Bankova V: Chemical diversity of propolis and the problem of
standardization. J Ethnopharmacol 2005, 100(1-2):114-117.
6. Velikova M, Bankova V, Marcucci MC, Tsvetkova I, Kujumgiev A: Chemical
composition and biological activity of propolis from Brazilian
meliponinae. Z Naturforsch [C] 2000, 55(9-10):785-789.
7. Pereira AL, Bicalho B, Aquino-Neto FR: Comparison of propolis from Apis
mellifera and Tetragonisca angustula. Apidologie 2003, 34:291-298.
8. Bankova V, Popova M: Propolis of stingless bees: a promising source of
biologically active compounds. Pharmacog Rev 2007, 1(1):88-92.
9. Roubik D: Ecology and Natural History of Tropical Bees. Cambridge:
Cambridge Univ. Press; 1989.
10. Kerr WE: Biologia e manejo da tiúba: a abelha do Maranhão. São Luís,
MA: EDUFMA; 1996.
11. Castaldo S, Capasso F: Propolis, an old remedy used in modern medicine.
Fitoterapia 2002, 73(Suppl 1):S1-6.
12. Quezada-Euan JJG, de Jesus May-Itza W, Gonzalez-Acereto JA:
Meliponiculture in Mexico: problems and perspectives for development.
Bee World 2001, 82:160-167.
13. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S:
Antibacterial, antifungal and antiviral activity of propolis of different
geographic origin. J Ethnopharmacol 1999, 64(3):235-240.
14. Farnesi AP, Aquino-Ferreira R, De Jong D, Bastos JK, Soares AE: Effects of
stingless bee and honey bee propolis on four species of bacteria. Genet
Mol Res 2009, 8(2):635-640.
15. Uzel A, Sorkun K, Oncag O, Cogulu D, Gencay O, Salih B: Chemical
compositions and antimicrobial activities of four different Anatolian
propolis samples. Microbiol Res 2005, 160(2):189-195.
16. Ikeno K, Ikeno T, Miyazawa C: Effects of propolis on dental caries in rats.
Caries Res 1991, 25(5):347-351.
17. Koo H, Gomes BP, Rosalen PL, Ambrosano GM, Park YK, Cury JA: In vitro
antimicrobial activity of propolis and Arnica montana against oral
pathogens. Arch Oral Biol 2000, 45(2):141-148.
18. Liberio SA, Pereira AL, Araujo MJ, Dutra RP, Nascimento FR, Monteiro-
Neto V, Ribeiro MN, Goncalves AG, Guerra RN: The potential use of
propolis as a cariostatic agent and its actions on mutans group
streptococci. J Ethnopharmacol 2009, 125(1):1-9.
19. Park YK, Koo MH, Abreu JA, Ikegaki M, Cury JA, Rosalen PL: Antimicrobial
activity of propolis on oral microorganisms. Curr Microbiol 1998,
36(1):24-28.
20. Sawaya ACHF, Souza KS, Marcucci MC, Cunha IBS, Shimizu MT: Analysis of
the composition of Brazilian propolis extracts by chromatography and
evaluation of their in vitro activity against gram-positive bacteria. Braz J
Microbiol 2004, 35(1-2):104-109.
21. Burdock GA: Review of the biological properties and toxicity of bee
propolis (propolis). Food Chem Toxicol 1998, 36(4):347-363.
22. Jasprica I, Mornar A, Debeljak Z, Smolcic-Bubalo A, Medic-Saric M, Mayer L,
Romic Z, Bucan K, Balog T, Sobocanec S, et al: In vivo study of propolis
supplementation effects on antioxidative status and red blood cells. J
Ethnopharmacol 2007, 110(3):548-554.
23. Mani F, Damasceno HCR, Novelli ELB, Martins EAM, Sforcin JM: Propolis:
Effect of different concentrations, extracts and intake period on seric
biochemical variables. J Ethnopharmacol 2006, 105:95-98.
24. Mohammadzadeh S, Shariatpanahi M, Hamedi M, Ahmadkhaniha R,
Samadi N, Ostad SN: Chemical composition, oral toxicity and
antimicrobial activity of Iranian propolis. Food Chem 2007, 103:1097-1103.
25. Moreno MIN, Zampini IC, Ordóñez RM, Jaime GS, Vattuone MA, Isla MI:
Evaluation of the cytotoxicity, genotoxicity, mutagenicity, and
antimutagenicity of propolis from Tucuman, Argentina. J Agric Food
Chem 2005, 53:8957-8962.
26. Ahuja A, (ed.): Handbook of Bioseparations New York: Academic Press; 2000.
27. Ferro VA, Bradbury F, Cameron P, Shakir E, Rahman SR, Stimson WH: In
vitro susceptibilities of Shigella flexneri and Streptococcus pyogenes to
inner gel of Aloe barbadensis Miller. Antimicrob Agents Chemother 2003,
47(3):1137-1139.
28. Koo H, Rosalen PL, Cury JA, Ambrosano GM, Murata RM, Yatsuda R,
Ikegaki M, Alencar SM, Park YK: Effect of a new variety of Apis mellifera
propolis on mutans Streptococci. Curr Microbiol 2000, 41(3):192-196.
29. Curran TM, Ma Y, Rutherford GC, Marquis RE: Turning on and turning off
the arginine deiminase system in oral streptococci. Can J Microbiol 1998,
44:1078-1085.
30. Koo H, Pearson SK, Scott-Anne K, Abranches J, Cury JA, Rosalen PL, Park YK,
Marquis RE, Bowen WH: Effects of apigenin and tt-farnesol on
glucosyltransferase activity, biofilm viability and caries development in
rats. Oral Microbiol Immunol 2002, 17(6):337-343.
31. Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH: Effects of compounds
found in propolis on Streptococcus mutans growth and on
glucosyltransferase activity. Antimicrob Agents Chemother 2002,
46(5):1302-1309.
32. Enríquez A, Prieto E, De Los Ríos E, Ruiz S: Estudio farmacognóstico y
fitoquímico del rizoma de Zingiber officinale Roscoe “Jengibre” de la
ciudad de Chanchamayo - Región Junín. Perú. Rev Med Vallejiana 2008,
5(1):50-64.
33. Woisky RGR, Salatino A: Analysis of propolis: some parameters and
procedures for chemical quality control. J Apic Res 1998, 37:99-105.
34. Matos FJA: Introdução à Fitoquímica Experimental. Fortaleza: UFC;, 3 2009.
Liberio et al. BMC Complementary and Alternative Medicine 2011, 11:108
http://www.biomedcentral.com/1472-6882/11/108
Page 9 of 1035. Brazil: Instrução Normativa n°3, de 19 de janeiro de 2001. Aprova os
regulamentos Técnicos de Identidade e Qualidade de Apitoxina, Cera de
Abelha, Geléia Real, Geléia Real Liofilizada, Pólen Apícola, Própolis e
Extrato de Própolis, conforme consta dos Anexos desta Instrução
Normativa.Edited by: Ministério da Agricultura PedA. Brasília DF: Diário
Oficial da União; 2001:18.
36. Alencar SM, Oldoni TL, Castro ML, Cabral IS, Costa-Neto CM, Cury JA,
Rosalen PL, Ikegaki M: Chemical composition and biological activity of a
new type of Brazilian propolis: red propolis. J Ethnopharmacol 2007,
113(2):278-283.
37. Steinberg D, Kaine G, Gedalia I: Antibacterial effect of propolis and honey
on oral bacteria. Am J Dent 1996, 9(6):236-239.
38. Koru O, Toksoy F, Acikel CH, Tunca YM, Baysallar M, Uskudar Guclu A,
Akca E, Ozkok Tuylu A, Sorkun K, Tanyuksel M, et al: In vitro antimicrobial
activity of propolis samples from different geographical origins against
certain oral pathogens. Anaerobe 2007, 13(3-4):140-145.
39. Loesche WJ: Role of Streptococcus mutans in human dental decay.
Microbiol Rev 1986, 50(4):353-380.
40. Marsh PD: Microbiologic aspects of dental plaque and dental caries. Dent
Clin North Am 1999, 43(4):599-614.
41. van Houte J: Role of micro-organisms in caries etiology. J Dent Res 1994,
73(3):672-681.
42. Duailibe SA, Goncalves AG, Ahid FJ: Effect of a propolis extract on
Streptococcus mutans counts in vivo. J Appl Oral Sci 2007, 15(5):420-423.
43. Duarte S, Rosalen PL, Hayacibara MF, Cury JA, Bowen WH, Marquis RE,
Rehder VL, Sartoratto A, Ikegaki M, Koo H: The influence of a novel
propolis on mutans streptococci biofilms and caries development in
rats. Arch Oral Biol 2006, 51(1):15-22.
44. Twetman S: Antimicrobials in future caries control? A review with special
reference to chlorhexidine treatment. Caries Res 2004, 38(3):223-229.
45. Apkan A, Morgan R: Oral candidiasis. J Postgrad Med 2002, 78:455-459.
46. Samaranayake LP: Oral candidosis: an old disease in new guises. Dent
Update 1990, 17(1):36-38.
47. Freitas MO, Ponte FAF, Lima MAS, Silveira ER: Flavonoids and Triterpenes
from the Nest of the Stingless Bee Trigona spinipes. J Braz Chem Soc
2008, 19(3):532-535.
48. Katircioglu H, Mercan N: Antimicrobial activity and chemical compositions
of Turkish propolis from different regions. Afr J Biotechnol 2006,
5:1151-1153.
49. Russo A, Longo R, Vanella A: Antioxidant activity of propolis: role of
caffeic acid phenethyl ester and galangin. Fitoterapia 2002, 73(Suppl 1):
S21-29.
50. Cushnie TPT, Lamb AJ: Antimicrobial activity of flavonoids. Int J Antimicrob
Agents 2005, 26(5):343-356.
51. Callejo A, Armentia A, Lombardero M, Asensio T: Propolis, a new bee-
related allergen. Allergy 2001, 56(6):579.
52. Walgrave SE, Warshaw EM, Glesne LA: Allergic contact dermatitis from
propolis. Dermatitis 2005, 16:209-215.
53. Bhadauria M, Nirala SK, Shukla S: Multiple treatment of propolis extract
ameliorates carbon tetrachloride induced liver injury in rats. Food Chem
Toxicol 2008, 46:2703-2712.
54. Ozen S, Akyol O, Iraz M, Sogut S, Ozugurlu F, Ozyurt H, Odaci E, Yildirim Z:
Role of caffeic acid phenethyl ester, an active component of propolis,
against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol 2004,
24:27-35.
55. Almeida AS, Faleiros ACG, Teixeira DNS, Cota UA, Chica JEL: Reference
values for blood-based biochemical parameters in BALB/c and C57BL/6
wild-type mice. Jornal Brasileiro Patol Med Lab 2008, 44(6):429-432.
56. Amin A, Hamza AA: Hepatoprotective effects of Hibiscus, Rosmarinus and
Salvia on azathioprine-induced toxicity in rats. Life Sciences 2005,
77:266-278.
57. Suja SR, Latha PG, Pushpangandan P, Rajasekharan S: Evaluation of
hepatoprotective effects of Helminthostachys zeylanica (L) Hook against
carbon tetrachloride induced liver damage in Wistar rats. J
Ethnopharmacol 2004, 92:61-66.
58. Pascual C, Gonzalez R, Torricella R: Scavenging action of propolis extract
against oxygen radicals. J Ethnopharmacol 1994, 41:9-13.
59. Wan YY, Flavell RA: The roles for cytokines in the generation and
maintenance of regulatory T cells. Immunol Rev 2006, 212:114-130.
60. Khayyal MT, El-Ghazaly MA, El-Khatib AS, Hatem AM, De Vries PJF, El-
Shafei S, Khattab MM: A clinical pharmacological study of the potential
beneficial effects of a propolis food product as an adjuvant in asthmatic
patients. Fund Clin Pharmacol 2003, 17:93-102.
61. Orsatti CL, Missima F, Pagliarone AC, Bachiega TC, Búfalo MC, Araújo JP Jr,
Sforcin JM: Propolis immunomodulatory action in vivo on Toll-Like
receptors 2 and 4 expression and on pro-inflammatory cytokines
production in mice. Phytother Res 2010, 24(8):1141-1146.
62. Orsi RO, Funari SR, Soares AMVC, Calvi SA, Oliveira SL, Sforcin JM,
Bankova V: Immunomodulatory action of propolis on macrophage
activation. J Venom AnimToxins 2000, 6(2):205-219.
63. Sforcin JM, Orsi RO, Bankova V: Effect of propolis, some isolated
compounds and its source plant on antibody production. J
Ethnopharmacol 2005, 98(3):301-305.
64. Ahn MR, Kumazawa S, Hamasaka T, Bang KS, Nakayama T: Antioxidant
activity and constituents of propolis collected in various areas of Korea.
J Agric Food Chem 2004, 52(24):7286-7292.
65. Orsolic N, Basic I: Antitumor, hematostimulative and radioprotective
action of water-soluble derivative of propolis (WSDP). Biomed
Pharmacother 2005, 59(10):561-570.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6882/11/108/prepub
doi:10.1186/1472-6882-11-108
Cite this article as: Liberio et al.: Antimicrobial activity against oral
pathogens and immunomodulatory effects and toxicity of geopropolis
produced by the stingless bee Melipona fasciculata Smith. BMC
Complementary and Alternative Medicine 2011 11:108.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liberio et al. BMC Complementary and Alternative Medicine 2011, 11:108
http://www.biomedcentral.com/1472-6882/11/108
Page 10 of 10